XML 40 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended
May 02, 2022
Apr. 08, 2022
Jan. 04, 2021
Jun. 30, 2021
Mar. 31, 2021
Shareholders' Equity (Details) [Line Items]          
Issuance of ordinary shares (in Shares)   1,000      
Bonus amount   $ 2     $ 27
Ordinary shares (in Shares) 450,000        
Purchase price per shares (in Dollars per share) $ 2.2        
Exercise price per shares (in Dollars per share) $ 2.2        
Total amount $ 990        
Net issuance expenses $ 911        
Exercise of options       $ 59  
Agreement, description     On January 4, 2021, the Company entered into a definitive agreement with several institutional investors for the sale of 800,000 units, each consisting of one ordinary share and 0.9 of a warrant to purchase an ordinary share at a combined purchase price of $2.5.  The warrants have an exercise price of $2.75 per share and are immediately exercisable into ordinary shares over a five-year term. The sale was made in a registered direct offering with a total gross amount of $2,000 or $1,841 net of incremental and direct issuance expenses.    
Ordinary Shares [Member]          
Shareholders' Equity (Details) [Line Items]          
Issuance of ordinary shares (in Shares)         7,188
Exercise of options       $ 25,399